Literature DB >> 7536794

Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein.

M M Wurfel1, E Hailman, S D Wright.   

Abstract

We have recently shown that lipopolysaccharide (LPS)-binding protein (LBP) is a lipid transfer protein that catalyzes two distinct reactions: movement of bacterial LPS (endotoxin) from LPS micelles to soluble CD14 (sCD14) and movement of LPS from micelles to reconstituted high density lipoprotein (R-HDL) particles. Here we show that LBP facilitates a third lipid transfer reaction: movement of LPS from LPS-sCD14 complexes to R-HDL particles. This action of LBP is catalytic, with one molecule of LBP enabling the movement of multiple LPS molecules into R-HDL. LBP-catalyzed movement of LPS from LPS-sCD14 complexes to R-HDL neutralizes the capacity of LPS to stimulate polymorphonuclear leukocytes. Our findings show that LPS may be transferred to R-HDL either by the direct action of LBP or by a two-step reaction in which LPS is first transferred to sCD14 and subsequently to R-HDL. We have observed that the two-step pathway of LPS transfer to R-HDL is strongly favored over direct transfer. Neutralization of LPS by LBP and R-HDL was accelerated more than 30-fold by addition of sCD14. Several observations suggest that sCD14 accelerates this reaction by serving as a shuttle for LPS: addition of LBP and sCD14 to LPS micelles resulted in LPS-sCD14 complexes that could diffuse through a 100-kD cutoff filter; LPS-sCD14 complexes appeared transiently during movement of LPS to R-HDL facilitated by purified LBP; and sCD14 could facilitate transfer of LPS to R-HDL without becoming part of the final LPS-R-HDL complex. Complexes of LPS and sCD14 were formed transiently when LPS was incubated in plasma, suggesting that these complexes may play a role as intermediates in the neutralization of LPS under physiological conditions. These findings detail a new activity for sCD14 and suggest a novel mechanism for lipid transfer by LBP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7536794      PMCID: PMC2191991          DOI: 10.1084/jem.181.5.1743

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  In vivo interaction of endotoxin with a plasma lipoprotein having esterase activity.

Authors:  R C Skarnes
Journal:  J Bacteriol       Date:  1968-06       Impact factor: 3.490

2.  Complete cDNA encoding human phospholipid transfer protein from human endothelial cells.

Authors:  J R Day; J J Albers; C E Lofton-Day; T L Gilbert; A F Ching; F J Grant; P J O'Hara; S M Marcovina; J L Adolphson
Journal:  J Biol Chem       Date:  1994-03-25       Impact factor: 5.157

3.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

Authors:  S D Wright; R A Ramos; P S Tobias; R J Ulevitch; J C Mathison
Journal:  Science       Date:  1990-09-21       Impact factor: 47.728

4.  A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits.

Authors:  A P Hubsch; F S Powell; P G Lerch; J E Doran
Journal:  Circ Shock       Date:  1993-05

5.  Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I.

Authors:  W A Flegel; M W Baumstark; C Weinstock; A Berg; H Northoff
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  In vivo protection against endotoxin by plasma high density lipoprotein.

Authors:  D M Levine; T S Parker; T M Donnelly; A Walsh; A L Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

7.  Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions.

Authors:  C E Matz; A Jonas
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

8.  Binding of Salmonella typhimurium lipopolysaccharides to rat high-density lipoproteins.

Authors:  R S Munford; C L Hall; J M Dietschy
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

9.  Soluble CD14 participates in the response of cells to lipopolysaccharide.

Authors:  E A Frey; D S Miller; T G Jahr; A Sundan; V Bazil; T Espevik; B B Finlay; S D Wright
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

10.  Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.

Authors:  E Hailman; H S Lichenstein; M M Wurfel; D S Miller; D A Johnson; M Kelley; L A Busse; M M Zukowski; S D Wright
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  72 in total

1.  Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide.

Authors:  Luis A Augusto; Monique Synguelakis; Jan Johansson; Thierry Pedron; Robert Girard; Richard Chaby
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 2.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

3.  Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide.

Authors:  C A Byrd; W Bornmann; H Erdjument-Bromage; P Tempst; N Pavletich; N Rosen; C F Nathan; A Ding
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

4.  Acute-phase concentrations of lipopolysaccharide (LPS)-binding protein inhibit innate immune cell activation by different LPS chemotypes via different mechanisms.

Authors:  Lutz Hamann; Christian Alexander; Cordula Stamme; Ulrich Zähringer; Ralf R Schumann
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 5.  Innate immunity in the lungs.

Authors:  Thomas R Martin; Charles W Frevert
Journal:  Proc Am Thorac Soc       Date:  2005

Review 6.  Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis.

Authors:  B Henderson; S Poole; M Wilson
Journal:  Microbiol Rev       Date:  1996-06

7.  Serum factors, cell membrane CD14, and beta2 integrins are not required for activation of bovine macrophages by lipopolysaccharide.

Authors:  T W Jungi; H Sager; H Adler; M Brcic; H Pfister
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

Review 8.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

Review 9.  Soluble CD14: role in atopic disease and recurrent infections, including otitis media.

Authors:  Karin C Lødrup Carlsen; Berit Granum
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

10.  Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression.

Authors:  Bing Du; Weijia Luo; Ruimei Li; Binghe Tan; Honghui Han; Xiaoling Lu; Dali Li; Min Qian; Dekai Zhang; Yongxiang Zhao; Mingyao Liu
Journal:  J Biol Chem       Date:  2013-04-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.